A screen for inducers of bHLH activity identifies pitavastatin as a regulator of p21, Rb phosphorylation and E2F target gene expression in pancreatic cancer

The average survival for patients with Pancreatic Ductal Adenocarcinoma (PDA) is merely 6 months, underscoring the need for new therapeutic approaches. During PDA progression, pancreatic acinar cells lose activity of the ClassI/II bHLH factors that regulate quiescence. We previously found that promo...

Descripción completa

Detalles Bibliográficos
Autores principales: Villarino, Nicholas, Signaevskaia, Lia, van Niekerk, Jaco, Medal, Rachel, Kim, Heejung, Lahmy, Reyhaneh, Scully, Kathleen, Pinkerton, Anthony, Kim, Sangwun, Lowy, Andrew, Itkin-Ansari, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581100/
https://www.ncbi.nlm.nih.gov/pubmed/28881801
http://dx.doi.org/10.18632/oncotarget.18587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581100/
https://www.ncbi.nlm.nih.gov/pubmed/28881801
http://dx.doi.org/10.18632/oncotarget.18587

Ejemplares similares